BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3489580)

  • 1. [Pentoxifylline in changes of the statoacoustic apparatus during vascular diseases. Its action on erythrocyte flexibility].
    Pallestrini E; Garaventa G; Cagetti P; Benedetti G; Valle MT; Accomando E; Castiglia G
    Clin Ter; 1986 Aug; 118(4):239-46. PubMed ID: 3489580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sudden deafness: apropos of 19 cases. Results of treatment with pentoxifylline. Value of erythrocyte filtration time].
    Denis F; Ketari M; Benzaken J; Renou G
    Ann Otolaryngol Chir Cervicofac; 1989; 106(1):21-6. PubMed ID: 2719437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 4. Pentoxifylline, diltiazem, and A23187: effects on deformability and volume of human red blood cells.
    Dodson RA; Hinds TR; Vincenzi FF
    Proc West Pharmacol Soc; 1988; 31():205-7. PubMed ID: 3145500
    [No Abstract]   [Full Text] [Related]  

  • 5. Pentoxifylline and intermittent claudication.
    Reilly DT
    N Z Med J; 1987 Oct; 100(833):640. PubMed ID: 3452126
    [No Abstract]   [Full Text] [Related]  

  • 6. Pentoxifylline and intermittent claudication.
    Simpson LO
    N Z Med J; 1987 Aug; 100(830):539. PubMed ID: 3452096
    [No Abstract]   [Full Text] [Related]  

  • 7. Pentoxifylline and intermittent claudication.
    Simpson LO
    N Z Med J; 1987 Nov; 100(835):693. PubMed ID: 3452154
    [No Abstract]   [Full Text] [Related]  

  • 8. [Erythrocyte deformability in progressive muscular dystrophy and effect of pentoxifylline].
    Chen SS; Liu JS
    Taiwan Yi Xue Hui Za Zhi; 1986 Mar; 85(3):249-57. PubMed ID: 3462309
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
    Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB
    Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte deformability in canine septic shock and the efficacy of pentoxifylline and a leukotriene antagonist.
    Puranapanda V; Hinshaw LB; O'Rear EA; Chang AC; Whitsett TL
    Proc Soc Exp Biol Med; 1987 Jun; 185(2):206-10. PubMed ID: 3554261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the pharmacology of pentoxifylline and its combination with low-dose acetylsalicylic acid (HWA 5112).
    Seiffge D; Weithmann KU
    Semin Thromb Hemost; 1989 Apr; 15(2):150-8. PubMed ID: 2749263
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the vasoocclusive crisis of sickle cell disease IV. Mechanism of action of pentoxifylline (Trental).
    Ambrus JL; Meky N; Stadler S; Sills RH; Gastpar H; Raposa T
    J Med; 1988; 19(2):67-88. PubMed ID: 3171402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
    Chyzy R; Lukjan H; Rość D; Bielawiec M; Sawicka J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):549-54. PubMed ID: 2446996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alopecia areata. Hemorheological study and treatment with pentoxifylline].
    Trevisan G; Cisilin MP
    G Ital Dermatol Venereol; 1988 May; 123(5):211-4. PubMed ID: 3209239
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pentoxifylline in the treatment of vertiginous syndromes: clinical contribution].
    Brunelli M; Costantini S
    Ric Clin Lab; 1989; 19 Suppl 1():129-31. PubMed ID: 2629072
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of pentoxifylline and prostaglandin E1 on cold blood perfusion studied by red blood cell deformability.
    Sakai A; Kikuchi Y; Ohshima N; Hori M
    Angiology; 1987 Jul; 38(7):514-9. PubMed ID: 3619124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pentoxifylline and metabolite on red blood cell deformability as measured by ektacytometry.
    Cummings DM; Ballas SK
    Angiology; 1990 Feb; 41(2):118-23. PubMed ID: 2306004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oscillography of the action of pentoxifylline in the treatment of disorders of the peripheral circulation].
    Galindo Planas N; Vallve C
    Angiologia; 1980; 32(2):81-90. PubMed ID: 7362070
    [No Abstract]   [Full Text] [Related]  

  • 19. Pentoxifylline and intermittent claudication.
    Spittel JA
    Ann Intern Med; 1985 Jan; 102(1):126-7. PubMed ID: 3966730
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of pentoxifylline on the ocular rheographic pulse in diabetic patients].
    Colombati S; Monti L; Baggiani M; Filippini F
    Ric Clin Lab; 1989; 19 Suppl 1():185-7. PubMed ID: 2629085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.